finasteride and Sex Disorders

finasteride has been researched along with Sex Disorders in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.27)18.2507
2000's5 (11.36)29.6817
2010's31 (70.45)24.3611
2020's7 (15.91)2.80

Authors

AuthorsStudies
Irwig, MS4
Bahrick, A; Bak, M; Barbato, A; Calabrò, RS; Chubak, BM; Cosci, F; Csoka, AB; D'Avanzo, B; Diviccaro, S; Giatti, S; Goldstein, I; Graf, H; Healy, D; Hellstrom, WJG; Irwig, MS; Jannini, EA; Janssen, PKC; Khera, M; Kumar, MT; Le Noury, J; Lew-Starowicz, M; Linden, DEJ; Lüning, C; Mangin, D; Melcangi, RC; Panicker, JN; Patacchini, A; Pearlman, AM; Pukall, CF; Raj, S; Reisman, Y; Rodríguez, OWMAAS; Rubin, RS; Schreiber, R; Shipko, S; Vašečková, B; Waraich, A1
Basaria, S; Bhojani, N; Chughtai, B; Cone, EB; Elterman, DS; Herzog, P; Labban, M; Nguyen, DD; Trinh, QD; Zorn, KC1
Gray, SL; Semla, TP1
Traish, AM1
Cargnelutti, F; Carlini, T; Lenzi, A; Lombardo, F; Pallotti, F; Paoli, D; Pelloni, M; Radicioni, AF; Rossi, A; Senofonte, G1
Choi, JY; Kang, MJ; Lew, BL; Sim, WY1
Borgo, F; Cavaletti, G; Diviccaro, S; Falvo, E; Giatti, S; Macandog, AD; Melcangi, RC1
Darwin, E; Fertig, RM; Gamret, AC; Gaudi, S1
Bergfeld, W; Murad, A1
Diviccaro, S; Giatti, S; Melcangi, RC; Panzica, G1
Mehta, A; Said, MA1
Althof, S; Baas, WR; Butcher, MJ; Clemons, J; Delfino, K; Herberts, M; Holland, B; Kohler, TS; Lwin, A; McVary, KT1
Choe, SJ; Lee, S; Lee, WS; Lee, YB1
Coskuner, ER; Culha, MG; Ozkan, B1
Kajdy, A; Maksym, RB; Rabijewski, M1
Carviel, JL; Epstein, E; Foley, KA; Gupta, AK; Haber, RS1
Cohen, BE; Goldberg, JE; Ho, RS; Motosko, CC; Zakhem, GA1
Canguven, O; Talib, RA1
Kaplan, SA1
Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F1
Choi, JW; Huh, CH; Jung, JY; Kim, BJ; Kwon, SH; Park, KC; Yeon, JH; Youn, SW1
Healy, D; Hogan, C; Le Noury, J; Mangin, D1
Ganzer, CA; Iqbal, F; Jacobs, AR1
Belgrano, E; Cauci, S; Di Loreto, C; La Marra, F; Mazzon, G; Trombetta, C1
Ali, AK; Etminan, M; Heran, BS1
Bortolato, M; Garcia-Segura, LM; Melcangi, RC; Traish, AM; Zitzmann, M1
Etminan, M; Flannigan, R; Guo, M; Heran, B; Kezouh, A1
Amr, S; Basaria, S; Bhasin, S; Bhawan, J; Dury, AY; Gonthier, R; Huang, G; Jasuja, R; Labrie, F; Li, Z; O'Leary, M; Pan, H; Papazian, A; Pencina, K; Serra, C; Stern, E; Storer, TW; Travison, TG; Wharton, W1
Sarvis, JA; Thompson, IM1
O'Leary, M1
Irwig, MS; Kolukula, S1
Gilling, P; Morrill, B; Nickel, JC; Rittmaster, RS; Tammela, TL; Wilson, TH1
Kuehn, BM1
Balercia, G; Corona, G; Forti, G; Maggi, M; Mannucci, E; Maseroli, E; Rastrelli, G; Sforza, A1
Gur, S; Hellstrom, WJ; Kadowitz, PJ1
Lee, M; Meehan, A; Roehrborn, CG; Waldstreicher, J1
Nehra, A1
Kuritzky, L1
Blumenstein, B; Brawley, OW; Coltman, CA; Crowley, J; Feigl, P; Ford, LG; Kramer, BS; Thompson, I; Wolf, M1

Reviews

15 review(s) available for finasteride and Sex Disorders

ArticleYear
Post-finasteride syndrome: a surmountable challenge for clinicians.
    Fertility and sterility, 2020, Volume: 113, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Clinical Trials as Topic; Finasteride; Humans; Male; Observational Studies as Topic; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Syndrome; Withholding Treatment

2020
Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Dermatology online journal, 2017, Nov-11, Volume: 23, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Dose-Response Relationship, Drug; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Sexual Dysfunction, Physiological

2017
5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Breast Neoplasms; Depression; Dutasteride; Evidence-Based Medicine; Female; Fibrosis; Finasteride; Forehead; Hair; Humans; Scalp; Sexual Dysfunction, Physiological

2018
Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
    Endocrine, 2018, Volume: 61, Issue:2

    Topics: Alopecia; Antidepressive Agents; Depression; Female; Finasteride; Humans; Iatrogenic Disease; Libido; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Syndrome

2018
The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Current urology reports, 2018, Jun-16, Volume: 19, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Infertility, Male; Libido; Male; Sexual Dysfunction, Physiological

2018
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Acta dermato-venereologica, 2019, 01-01, Volume: 99, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Alopecia; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological

2019
Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Sexual medicine reviews, 2019, Volume: 7, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological

2019
Post-finasteride syndrome - does it really exist?
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2019, Volume: 22, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug-Related Side Effects and Adverse Reactions; Finasteride; Humans; Iatrogenic Disease; Male; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological

2019
Sexual dysfunction in men taking systemic dermatologic medication: A systematic review.
    Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Cyclosporine; Dermatologic Agents; Finasteride; Humans; Itraconazole; Male; Middle Aged; Prevalence; Prognosis; Risk Assessment; Sexual Dysfunction, Physiological

2019
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
    The journal of sexual medicine, 2014, Volume: 11, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents

2014
Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?
    Reviews in endocrine & metabolic disorders, 2015, Volume: 16, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Animals; Central Nervous System; Cholestenone 5 alpha-Reductase; Cognition Disorders; Depression; Diabetes Mellitus; Dutasteride; Finasteride; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Psychoses, Substance-Induced; Sexual Dysfunction, Physiological; Steroids

2015
Prostate cancer chemoprevention: update of the prostate cancer prevention trial findings and implications for clinical practice.
    Current oncology reports, 2008, Volume: 10, Issue:6

    Topics: Aged; Chemoprevention; Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Placebos; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Risk; Sexual Dysfunction, Physiological

2008
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
    Expert opinion on drug safety, 2013, Volume: 12, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Male; Penile Erection; Prevalence; Prostatic Hyperplasia; Quality of Life; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Treatment Outcome

2013
Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia.
    BJU international, 2005, Volume: 96, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Penile Erection; Prostatic Hyperplasia; Sexual Dysfunction, Physiological

2005
Noninvasive management of lower urinary tract symptoms and sexual dysfunction associated with benign prostatic hyperplasia in the primary care setting.
    Comprehensive therapy, 2005,Fall, Volume: 31, Issue:3

    Topics: Adrenergic alpha-Antagonists; Azasteroids; Clinical Trials as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Primary Health Care; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Urination Disorders

2005

Trials

3 trial(s) available for finasteride and Sex Disorders

ArticleYear
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
    BJU international, 2011, Volume: 108, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Double-Blind Method; Dutasteride; Finasteride; Gynecomastia; Humans; Hypertension; Male; Middle Aged; Organ Size; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Treatment Outcome

2011
Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.
    Urology, 2003, Volume: 62, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Aged; Body Composition; Body Mass Index; Body Weight; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome

2003
Design of the Prostate Cancer Prevention Trial (PCPT).
    Controlled clinical trials, 1995, Volume: 16, Issue:3

    Topics: Aged; Bias; Confounding Factors, Epidemiologic; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Random Allocation; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sample Size; Sexual Dysfunction, Physiological; United States

1995

Other Studies

26 other study(ies) available for finasteride and Sex Disorders

ArticleYear
How routine pharmacovigilance failed to identify finasteride's persistent sexual side effects.
    Andrology, 2022, Volume: 10, Issue:2

    Topics: Finasteride; Genital Diseases, Male; Humans; Male; Pharmacovigilance; Sexual Dysfunction, Physiological; Syndrome; Urological Agents

2022
Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.
    The International journal of risk & safety in medicine, 2022, Volume: 33, Issue:1

    Topics: Adolescent; Antidepressive Agents; Child; Finasteride; Humans; Isotretinoin; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological

2022
Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase.
    Journal of the American Academy of Dermatology, 2023, Volume: 88, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Humans; Male; Pharmacovigilance; Sexual Dysfunction, Physiological

2023
Post-finasteride syndrome.
    BMJ (Clinical research ed.), 2019, 08-09, Volume: 366

    Topics: 5-alpha Reductase Inhibitors; Finasteride; Humans; Male; Mental Disorders; Sexual Dysfunction, Physiological; Syndrome; Withholding Treatment

2019
Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function.
    Endocrine, 2020, Volume: 68, Issue:3

    Topics: Alopecia; Finasteride; Humans; Male; Reproduction; Retrospective Studies; Sexual Dysfunction, Physiological

2020
5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Humans; Male; Middle Aged; Retrospective Studies; Sexual Dysfunction, Physiological; Treatment Outcome

2021
Alterations of gut microbiota composition in post-finasteride patients: a pilot study.
    Journal of endocrinological investigation, 2021, Volume: 44, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Biodiversity; Cognitive Dysfunction; Correlation of Data; Depression; Drug-Related Side Effects and Adverse Reactions; Finasteride; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Physical Functional Performance; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sexual Dysfunction, Physiological

2021
A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.
    Urology, 2018, Volume: 120

    Topics: 5-alpha Reductase Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Datasets as Topic; Dose-Response Relationship, Drug; Drug Eruptions; Fatigue; Finasteride; Gynecomastia; Hearing Disorders; Humans; Libido; Male; Memory Disorders; Middle Aged; Muscle Weakness; Prostatitis; Sexual Dysfunction, Physiological; Sleep Wake Disorders; United States; United States Food and Drug Administration

2018
Finasteride 1 mg in alopecia: sexual dysfunction, suicidal ideation. Providing balanced information to male patients is key.
    Prescrire international, 2016, Volume: 25, Issue:175

    Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Aged; Alopecia; Finasteride; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Suicidal Ideation; Young Adult

2016
Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey-based, single-centre, controlled study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:7

    Topics: Adolescent; Adult; Alopecia; Case-Control Studies; Dermatologic Agents; Finasteride; Humans; Libido; Middle Aged; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Young Adult

2019
Persistent sexual side effects of finasteride: could they be permanent?
    The journal of sexual medicine, 2013, Volume: 10, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Humans; Male; Sexual Dysfunction, Physiological

2013
Decreased alcohol consumption among former male users of finasteride with persistent sexual side effects: a preliminary report.
    Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Adult; Alcohol Drinking; Central Nervous System Depressants; Drinking Behavior; Ethanol; Finasteride; Humans; Male; Middle Aged; Neurotransmitter Agents; Sexual Dysfunction, Physiological; Young Adult

2013
Re: inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
    The Journal of urology, 2014, Volume: 191, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Azasteroids; Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sleep Wake Disorders

2014
Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    International journal of dermatology, 2014, Volume: 53, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Azasteroids; Dutasteride; Finasteride; Hair; Humans; Male; Photography; Retreatment; Sexual Dysfunction, Physiological; Treatment Failure

2014
One hundred and twenty cases of enduring sexual dysfunction following treatment.
    The International journal of risk & safety in medicine, 2014, Volume: 26, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Aged; Female; Finasteride; Humans; Isotretinoin; Keratolytic Agents; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Young Adult

2014
Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
    American journal of men's health, 2015, Volume: 9, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Adult; Affective Symptoms; Alopecia; Cognition Disorders; Finasteride; Health Surveys; Humans; Internet; Long Term Adverse Effects; Male; Middle Aged; Pilot Projects; Sexual Dysfunction, Physiological; Young Adult

2015
Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Case-Control Studies; Finasteride; Foreskin; Humans; Immunohistochemistry; Male; Middle Aged; Receptors, Androgen; Retrospective Studies; Sexual Dysfunction, Physiological; Testosterone; Young Adult

2014
Androgen levels and semen parameters among former users of finasteride with persistent sexual adverse effects.
    JAMA dermatology, 2014, Volume: 150, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia Areata; Dihydrotestosterone; Finasteride; Humans; Male; Sexual Dysfunction, Physiological; Sperm Count; Sperm Motility; Spermatozoa; Testosterone

2014
Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
    Pharmacotherapy, 2015, Volume: 35, Issue:7

    Topics: 5-alpha Reductase Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Databases, Factual; Finasteride; Humans; Male; Middle Aged; Pharmacovigilance; Sexual Dysfunction, Physiological; Suicidal Ideation; Young Adult

2015
Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss.
    Pharmacotherapy, 2016, Volume: 36, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Cohort Studies; Finasteride; Humans; Middle Aged; Omeprazole; Retrospective Studies; Sexual Dysfunction, Physiological; Time Factors

2016
Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgens; Depressive Disorder, Major; Finasteride; Gene Expression; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Androgen; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Young Adult

2016
By the way, doctor. Finasteride has been prescribed for my BPH. I think that the most frequent side effect is erectile dysfunction or loss of sexual desire. Would Levita or a similar drug (like Viagra or Cialis) overcome the side effects of finasteride
    Harvard health letter, 2009, Volume: 34, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Drug Synergism; Enzyme Inhibitors; Finasteride; Humans; Imidazoles; Male; Piperazines; Prostatic Hyperplasia; Purines; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents

2009
Persistent sexual side effects of finasteride for male pattern hair loss.
    The journal of sexual medicine, 2011, Volume: 8, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Chronic Disease; Dose-Response Relationship, Drug; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Sexual Dysfunction, Physiological; Young Adult

2011
Prostate, baldness drugs linked to sexual dysfunction.
    JAMA, 2012, May-09, Volume: 307, Issue:18

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Labeling; Finasteride; Humans; Infertility, Male; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; United States; United States Food and Drug Administration

2012
Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
    Journal of endocrinological investigation, 2012, Volume: 35, Issue:10

    Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Case-Control Studies; Cholestenone 5 alpha-Reductase; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Hyperplasia; Retrospective Studies; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Testosterone

2012
Persistent sexual side effects of finasteride: could they be permanent?
    The journal of sexual medicine, 2012, Volume: 9, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Chronic Disease; Finasteride; Humans; Male; Middle Aged; Prospective Studies; Sexual Dysfunction, Physiological

2012